首页> 美国卫生研究院文献>Indian Journal of Clinical Biochemistry >Urinary Urea Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients
【2h】

Urinary Urea Uric Acid and Hippuric Acid as Potential Biomarkers in Multiple Sclerosis Patients

机译:尿素尿酸和马尿酸是多发性硬化症患者的潜在生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Urine is a proven source of metabolite biomarkers and has the potential to be a rapid, noninvasive, inexpensive, and efficient diagnostic tool for various human diseases. Despite these advantages, urine is an under-investigated source of biomarkers for multiple sclerosis (MS). The objective was to investigate the level of some urinary metabolites (urea, uric acid and hippuric acid) in patients with MS and correlate their levels to the severity of the disease, MS subtypes and MS treatment. The urine samples were collected from 73 MS patients-48 with RRMS and 25 with SPMS- and age matched 75 healthy controls. The values of urinary urea, uric acid and hippuric acid in MS patients were significantly decreased, and these metabolites in SPMS pattern showed significantly decrease than RRMS pattern. Also showed significant inverse correlation with expanded disability status scale and number of relapses. Accordingly, they may act as a potential urinary biomarkers for MS, and correlate to disease progression.
机译:尿液是代谢物生物标志物的可靠来源,有潜力成为针对各种人类疾病的快速,无创,廉价和高效的诊断工具。尽管有这些优点,但尿液是多发性硬化症(MS)生物标志物的研究不足。目的是研究MS患者的某些尿代谢产物(尿素,尿酸和马尿酸)的水平,并将其水平与疾病的严重程度,MS亚型和MS治疗相关联。尿液样本来自73名MS患者-48名RRMS患者和25名SPMS患者-年龄匹配的75名健康对照者。 MS患者的尿素,尿酸和马尿酸值显着降低,SPMS模式中的这些代谢产物比RRMS模式显着降低。还显示出与扩展的残疾状态量表和复发次数显着负相关。因此,它们可以作为MS的潜在尿液生物标志物,并与疾病进展相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号